Jingyi Li, Yaqi Zhang, Miaorong Yu, Aohua Wang, Yu Qiu, Weiwei Fan, Lars Hovgaard, Mingshi Yang, Yiming Li, Rui Wang, Xiuying Li, Yong Gan. Author correction to “The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery” Acta Pharm Sin B 12 (2022) 1460-1472J. Acta Pharmaceutica Sinica B, 2025, 15(6): 3353-3353. DOI: 10.1016/j.apsb.2025.04.015
|
Citation:
|
Jingyi Li, Yaqi Zhang, Miaorong Yu, Aohua Wang, Yu Qiu, Weiwei Fan, Lars Hovgaard, Mingshi Yang, Yiming Li, Rui Wang, Xiuying Li, Yong Gan. Author correction to “The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery” Acta Pharm Sin B 12 (2022) 1460-1472J. Acta Pharmaceutica Sinica B, 2025, 15(6): 3353-3353. DOI: 10.1016/j.apsb.2025.04.015
|
Jingyi Li, Yaqi Zhang, Miaorong Yu, Aohua Wang, Yu Qiu, Weiwei Fan, Lars Hovgaard, Mingshi Yang, Yiming Li, Rui Wang, Xiuying Li, Yong Gan. Author correction to “The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery” Acta Pharm Sin B 12 (2022) 1460-1472J. Acta Pharmaceutica Sinica B, 2025, 15(6): 3353-3353. DOI: 10.1016/j.apsb.2025.04.015
|
Citation:
|
Jingyi Li, Yaqi Zhang, Miaorong Yu, Aohua Wang, Yu Qiu, Weiwei Fan, Lars Hovgaard, Mingshi Yang, Yiming Li, Rui Wang, Xiuying Li, Yong Gan. Author correction to “The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery” Acta Pharm Sin B 12 (2022) 1460-1472J. Acta Pharmaceutica Sinica B, 2025, 15(6): 3353-3353. DOI: 10.1016/j.apsb.2025.04.015
|